Liquid Chromatography–Tandem Mass Spectrometry Quantification of Diet‐Derived CYP2D6 Biomarkers for Clinical Phenotyping in Japanese Subjects
Clinical and Translational Science · 2026-08 · 19 (8)
DOI: 10.1111/cts.70668 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Science, online erschienen am 20.07.2026. Verfasst von Masaki Kumondai und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai, Japan. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Cytochrome P-450 CYP2D6, Liquid Chromatography-Mass Spectrometry, Diet. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The enzymatic activity of cytochrome P450 2D6 (CYP2D6) exhibits substantial interindividual variation, which influences drug efficacy and the risk of adverse drug reactions to various therapeutics. While current protocols for CYP2D6 genotyping or CYP2D6 phenotyping provide useful information, less invasive and simpler tools are desirable for evaluating interindividual functional variety. Recently, solanidine (SND) and its metabolites have been proposed as biomarkers of CYP2D6 activity. In this study, we established a validated analytical method to quantify SND and its metabolites. Moreover, their utility in predicting CYP2D6 activity in the Japanese population was assessed. We synthesized and structurally confirmed 4‐hydroxysolanidine (4‐OHSND) and developed a liquid chromatography–tandem mass spectrometry (LC–MS/MS) method for the simultaneous measurement of SND, 4‐OHSND, and 3,4‐seco‐solanidine‐3,4‐dioic acid (SSDA). This method was applied to plasma samples from 94 participants to investigate the CYP2D6 genotypes. The 4‐OHSND to SND and SSDA to SND ratios showed substantial differences corresponding to the predicted CYP2D6 phenotype groups, with a marked reduction in poor metabolizers (PMs). Receiver operating characteristic analyses demonstrated complete discrimination of PMs (AUC = 1.00). In contrast, weak positive correlations were identified between SND biomarkers and certain tamoxifen metabolic ratios. These findings confirm the structural identity and quantitative detectability of 4‐OHSND and support its potential as a practical biomarker for CYP2D6 PM detection. Although validation in larger and more diverse cohorts remains necessary, diet‐derived biomarkers may represent a minimally invasive alternative to genotyping or probe‐based approaches and may contribute to the broad implementation of phenotype‐guided personalized medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai, Japan.
- Faculty of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
- Laboratory of Oncology, Pharmacy Practice and Sciences, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
- Department of Breast and Endocrine Surgical Oncology, Graduate School of Medicine, Tohoku University, Sendai, Japan.
- Laboratory of Biomolecule and Pathophysiological Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
ORCID-Profile: Masaki Kumondai, Nagomi Hayashi, Yotaro Matsumoto, Akiko Ebata, Narumi Harada-Shoji, Minoru Miyashita, Masamitsu Maekawa, Nariyasu Mano
Zitieren
APA
Kumondai, M., Hayashi, N., Matsumoto, Y., Ebata, A., Sato, M., Harada-Shoji, N., Tada, H., Miyashita, M., Ishida, T., Maekawa, M., Tomioka, Y., & Mano, N. (2026). Liquid Chromatography–Tandem Mass Spectrometry Quantification of Diet‐Derived CYP2D6 Biomarkers for Clinical Phenotyping in Japanese Subjects. Clinical and Translational Science, 19(8). https://doi.org/10.1111/cts.70668
Vancouver
Kumondai M, Hayashi N, Matsumoto Y, Ebata A, Sato M, Harada-Shoji N, et al. Liquid Chromatography–Tandem Mass Spectrometry Quantification of Diet‐Derived CYP2D6 Biomarkers for Clinical Phenotyping in Japanese Subjects. Clinical and Translational Science. 2026;19(8). doi:10.1111/cts.70668
BibTeX
@article{Kumondai2026,
author = {Kumondai, Masaki and Hayashi, Nagomi and Matsumoto, Yotaro and Ebata, Akiko and Sato, Miku and Harada-Shoji, Narumi and Tada, Hiroshi and Miyashita, Minoru and Ishida, Takanori and Maekawa, Masamitsu and Tomioka, Yoshihisa and Mano, Nariyasu},
title = {Liquid Chromatography–Tandem Mass Spectrometry Quantification of Diet‐Derived CYP2D6 Biomarkers for Clinical Phenotyping in Japanese Subjects},
journal = {Clinical and Translational Science},
year = {2026},
volume = {19},
number = {8},
doi = {10.1111/cts.70668}
}
EUVIMED